E. Burn

First name
E.
Last name
Burn
Pinedo-Villanueva, R., Kolovos, S., Burn, E., Delmestri, A., Smith, L. K., Judge, A., et al. (2023). Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study. Bmc Musculoskelet Disord, 24, 106. http://doi.org/10.1186/s12891-023-06190-7
View
Broekstra, D. C., Kuo, R. Y. L., Burn, E., Prieto-Alhambra, D., & Furniss, D. (2022). Dupuytren's disease: Prevalence, incidence, and lifetime risk of surgical intervention A population-based cohort analysis. Plast Reconstr Surg. http://doi.org/10.1097/prs.0000000000009919
View
Burn, E., Li, X., Delmestri, A., Jones, N., Duarte-Salles, T., Reyes, C., et al. (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun, 13, 7167. http://doi.org/10.1038/s41467-022-34668-w
View
Li, X., Burn, E., Duarte-Salles, T., Yin, C., Reich, C., Delmestri, A., et al. (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
View
Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
View
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373
View
Burn, E., Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., et al. (2018). Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014. BMJ Open. http://doi.org/10.1136/bmjopen-2017-019146
View
Burn, E., Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., et al. (2019). The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2019.05.012
View
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., et al. (2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771
View
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., et al. (2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9
View